VolitionRX Ltd (VNRX) Price Prediction & ForecastVNRXVolitionRX Ltd

Alphio's VNRX stock price prediction model matches the current VolitionRX Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.20 (+2.57%). The 1-week path is $0.22 (+11.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

VolitionRX Ltd (VNRX) is currently trading at $0.1936, significantly below its 52-week high of $8.13, indicating potential for upside. However, the company has a troubling year-to-date change of -96.45% and a forward P/E ratio of 20.83, which suggests that while there is growth potential, it is not without risk. The recent partnership with Sysmex for optimizing diagnostic processes highlights a positive catalyst, but the company also reported a net income loss of -$7,326,047 in Q2 2026, which raises concerns about profitability. The RSI is at 52.60, indicating neutral momentum, and the stock is currently a penny stock, which adds to its volatility. The main risk is the high operating expenses that reached $6.3 million in Q1 2026, which could continue to pressure the company's financial health.

VolitionRX Ltd (VNRX) last closed at $0.1936, gaining +2.43%. These facts feed the 1-day and 1-week VNRX price prediction above.